GLIOBLASTOMA WHO GRADE IV
Clinical trials for GLIOBLASTOMA WHO GRADE IV explained in plain language.
Never miss a new study
Get alerted when new GLIOBLASTOMA WHO GRADE IV trials appear
Sign up with your email to follow new studies for GLIOBLASTOMA WHO GRADE IV, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug-radiation combo targets deadly brain tumors in early trial
Disease control OngoingThis early-phase trial tests whether adding the drug quisinostat to standard radiation therapy can help control grade 4 glioblastoma, a fast-growing brain cancer. It includes up to 30 adults with either newly-diagnosed or recurrent tumors. Researchers first measure how much drug …
Matched conditions: GLIOBLASTOMA WHO GRADE IV
Phase: EARLY_PHASE1 • Sponsor: Nader Sanai • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
New hope for brain cancer: triple therapy targets deadliest tumor
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab to standard treatment (temozolomide chemotherapy and Tumor Treating Fields) can help people with newly diagnosed glioblastoma live longer without their cancer growing. About 40 adults with this aggressive brain …
Matched conditions: GLIOBLASTOMA WHO GRADE IV
Phase: PHASE2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC